Senseonics Holdings (SENS)
Nasdaq Market Closed
Senseonics Holdings, Inc. is a medical technology company focused on continuous glucose monitoring for people living with diabetes. Its core product family, Eversense, is designed around a sensor placed under the skin by a healthcare professional, paired with a removable smart transmitter and a mobile app that displays glucose information in real time. This approach differentiates Senseonics from conventional wearable CGM systems that use shorter-duration disposable sensors applied externally.
The company’s systems are intended to help users monitor glucose trends, receive alerts, and make more informed treatment and lifestyle decisions. Eversense E3 extends sensor wear for up to six months, while Eversense 365 is designed for one-year use, positioning the platform around longer sensor life and fewer sensor changes. The transmitter can be taken off and reattached, which may appeal to users who want flexibility during activities such as exercise, bathing, or charging.
Senseonics generates revenue from diabetes-related products and services, with the United States representing its primary market. The company works in a highly competitive CGM industry that includes large diabetes device manufacturers, making regulatory approvals, payer coverage, clinical performance, and commercial partnerships important to its growth prospects. Its technology targets a large chronic disease market in which demand for real-time glucose data continues to expand as patients, clinicians, and health systems seek better tools for diabetes management.
Last updated
- Market Cap
- 372.21M
- P/E
- —
- P/FCF
- —
- P/S
- 9.14
- Enterprise Value
- 378.51M
- Sector
- —
- Industry
- Industrial Instruments for Measurement, Display, and Control of Process Variables; and Related Products
- Address
- 20451 SENECA MEADOWS PARKWAY, GERMANTOWN, MD, 20876
Senseonics Announces Pricing of $80 Million Public Offering of Common Stock and Pre-Funded Warrants
Middle East and Africa Continuous Glucose Monitoring Market Forecast and Company Analysis Report 2026-2034 Featuring Dexcom, Medtronic, Senseonics, Abbott Diabetes Care, and GlySens
Senseonics Announces European Launch of Eversense® 365, The World’s First and Only One Year CGM System
First Ever Real-World Evidence of Eversense 365 Presented at ATTD Demonstrates Sustained Performance and Positive Impact Throughout One-Year of Wear
Senseonics Holdings, Inc. Announces Closing of Public Offering, Including Exercise in Full of the Underwriters’ Option to Purchase Additional Shares, and Closing of Private Placement
Diabetic Care Device Market Set for Significant Growth with 10.1% CAGR
Senseonics Holdings, Inc. Announces Business Updates Including Preliminary 2024 Results, 365 Launch Update and Cancellation of Special Meeting
Eversense 365 Receives FDA Clearance: The World’s First One Year CGM
[Latest] US Diabetes Devices Market Size/Share Worth USD - GlobeNewswire
Senseonics' (SENS) Deal With Mercy to Drive Eversense CGM Sales
Clover Health Investments, Corp. (CLOV) Reports Q1 Loss, Tops Revenue Estimates
Senseonics Holdings (SENS) Reports Q4 Loss, Tops Revenue Estimates
Top Penny Stocks To Buy Now? 4 To Watch Under $4
5 Hot Penny Stocks To Watch Today
Phreesia (PHR) Surges 10.3%: Is This an Indication of Further Gains?
3 Top Penny Stocks To Buy Now According To Insiders
Senseonics Holdings (SENS) Reports Q2 Loss, Misses Revenue Estimates
10x Genomics (TXG) Reports Q2 Loss, Tops Revenue Estimates
Best Penny Stocks To Buy Now? 6 Under $1 To Watch Now
3 Penny Stocks Under $1 To Watch Before August 2023
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- 372.21M
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- 378.51M
- P/E
P/E ratio compares a company's share price to its earnings per share.
- —
- P/B
P/B ratio compares a company's share price to its book value per share.
- 10.84
- P/S
P/S ratio compares a company's share price to its revenue per share.
- 9.14
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- -4.45
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- 9.3
- EPS
- -1.67
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 0%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- —
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- —
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- -75.87M
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- -253.93%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- -84.77%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- 1.05
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 3.49
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 3.18
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 1.12
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- 1.08M
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 7.13
Income Statement
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Revenue | 11.71M | 14.26M | 8.1M | 6.65M | 6.26M |
| Gross profit | 6.94M | 7.67M | 3.47M | 3.12M | 1.51M |
| Operating income | -31.85M | -20.93M | -19.6M | -14.32M | -13.49M |
| EBITDA | -31.3M | -20.54M | -19.23M | -13.95M | -13.1M |
| Net income | -32.33M | -20.82M | -19.53M | -14.5M | -14.26M |
| Basic EPS | -0.71 | -0.47 | -0.43 | -0.4 | -0.4 |
| Diluted EPS | -0.71 | -0.47 | -0.43 | -0.4 | -0.4 |
Balance Sheet
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Total assets | 102.86M | 126.27M | 139.92M | 150.27M | 87.21M |
| Total liabilities | 68.52M | 65.22M | 61.76M | 55.55M | 52.01M |
| Total equity | 34.34M | 61.05M | 78.17M | 94.72M | 35.2M |
| Cash & equivalents | 29.61M | 40.23M | 34.46M | 31.52M | 39.31M |
| Current assets | 91.97M | 117.22M | 130.96M | 141.27M | 78.06M |
| Current liabilities | 26.33M | 24.35M | 21.07M | 14.78M | 11.38M |
Cash Flow
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Operating cash flow | -32.03M | -17.97M | -15.82M | -9.27M | -16.08M |
| Investing cash flow | 18M | 22.64M | 18.89M | -69.63M | -25.33M |
| Financing cash flow | 3.41M | 1.1M | -134K | 71.11M | 6.12M |
| Change in cash | -10.62M | 5.78M | 2.94M | -7.79M | -35.29M |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | SD — Senseonics Holdings, Inc. | View Filing | |
| edgar index | 4 — Senseonics Holdings, Inc. | View Filing | |
| edgar index | 4 — Senseonics Holdings, Inc. | View Filing | |
| edgar index | 4 — Senseonics Holdings, Inc. | View Filing | |
| edgar index | 4 — Senseonics Holdings, Inc. | View Filing | |
| edgar index | 4 — Senseonics Holdings, Inc. | View Filing | |
| edgar index | 4 — Senseonics Holdings, Inc. | View Filing | |
| edgar index | 4 — Senseonics Holdings, Inc. | View Filing | |
| edgar index | 4 — Senseonics Holdings, Inc. | View Filing | |
| edgar index | 4 — Senseonics Holdings, Inc. | View Filing | |
| edgar index | 4 — Senseonics Holdings, Inc. | View Filing | |
| edgar index | 4 — Senseonics Holdings, Inc. | View Filing | |
| edgar index | 4 — Senseonics Holdings, Inc. | View Filing | |
| edgar index | 8-K — Senseonics Holdings, Inc. | View Filing | |
| edgar index | S-8 — Senseonics Holdings, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| form 4 | Form 4 — ROEDER DOUGLAS A | View Filing | |
| form 4 | Form 4 — ROEDER DOUGLAS A | View Filing | |
| form 4 | Form 4 — DeFalco Stephen P | View Filing | |
| form 4 | Form 4 — DeFalco Stephen P | View Filing | |
| form 4 | Form 4 — Fiorentino Edward | View Filing | |
| form 4 | Form 4 — Fiorentino Edward | View Filing | |
| form 4 | Form 4 — Prince Douglas S | View Filing | |
| form 4 | Form 4 — Prince Douglas S | View Filing | |
| form 4 | Form 4 — Steven Edelman | View Filing | |
| form 4 | Form 4 — Steven Edelman | View Filing | |
| form 4 | Form 4 — Larkin Sharon | View Filing | |
| form 4 | Form 4 — Larkin Sharon | View Filing | |
| form 4 | Form 4 — HANSEN BRIAN B | View Filing | |
| form 4 | Form 4 — HANSEN BRIAN B | View Filing | |
| form 4 | Form 4 — Horton Kenneth L | View Filing | |
| form 4 | Form 4 — Horton Kenneth L | View Filing | |
| form 4 | Form 4 — Goodnow Timothy T | View Filing | |
| form 4 | Form 4 — Goodnow Timothy T | View Filing | |
| form 4 | Form 4 — JAIN Mukul | View Filing | |
| form 4 | Form 4 — JAIN Mukul | View Filing | |
| form 4 | Form 4 — Kaufman Francine | View Filing | |
| form 4 | Form 4 — Kaufman Francine | View Filing | |
| form 4 | Form 4 — Sullivan Frederick T. | View Filing | |
| form 4 | Form 4 — Sullivan Frederick T. | View Filing | |
| edgar index | 4 — Senseonics Holdings, Inc. | View Filing | |
| edgar index | 4 — Senseonics Holdings, Inc. | View Filing | |
| edgar index | 4 — Senseonics Holdings, Inc. | View Filing | |
| edgar index | 4 — Senseonics Holdings, Inc. | View Filing | |
| edgar index | 4 — Senseonics Holdings, Inc. | View Filing | |
| form 4 | Form 4 — Horton Kenneth L | View Filing | |
| form 4 | Form 4 — Goodnow Timothy T | View Filing | |
| form 4 | Form 4 — JAIN Mukul | View Filing | |
| form 4 | Form 4 — Kaufman Francine | View Filing | |
| form 4 | Form 4 — Sullivan Frederick T. | View Filing | |
| edgar index | 4 — Senseonics Holdings, Inc. | View Filing | |
| form 4 | Form 4 — ROEDER DOUGLAS A | View Filing | |
| edgar index | 8-K — Senseonics Holdings, Inc. | View Filing | |
| edgar index | 10-Q — Senseonics Holdings, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — Senseonics Holdings, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — Senseonics Holdings, Inc. | View Filing | |
| edgar index | 424B5 — Senseonics Holdings, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | DEFR14A — Senseonics Holdings, Inc. | View Filing | |
| edgar index | DEF 14A — Senseonics Holdings, Inc. | View Filing | |
| edgar index | DEFA14A — Senseonics Holdings, Inc. | View Filing | |
| edgar index | ARS — Senseonics Holdings, Inc. | View Filing | |
| edgar index | 4 — Senseonics Holdings, Inc. | View Filing | |
| edgar index | 4 — Senseonics Holdings, Inc. | View Filing | |
| edgar index | 4 — Senseonics Holdings, Inc. | View Filing | |
| edgar index | 4 — Senseonics Holdings, Inc. | View Filing | |
| form 4 | Form 4 — ROEDER DOUGLAS A | View Filing | |
| form 4 | Form 4 — Fiorentino Edward | View Filing | |
| form 4 | Form 4 — Prince Douglas S | View Filing | |
| form 4 | Form 4 — Steven Edelman | View Filing | |
| edgar index | PRE 14A — Senseonics Holdings, Inc. | View Filing | |
| edgar index | 4 — Senseonics Holdings, Inc. | View Filing | |
| edgar index | 4 — Senseonics Holdings, Inc. | View Filing |